Boyds

We are delighted to announce the appointment of Dr Katherine Bowen to Vice President of Regulatory Affairs. Katherine joined Boyds in 2022 as Senior Director of Regulatory Affairs. Since then, she has led client projects, providing strategic and operational regulatory advice to facilitate regulatory input, incentives, and early market access. In her new role, Katherine will head up our Regulatory Affairs offering, supporting biotechs and pharma companies across the globe, as well as joining Boyds’ Executive Leadership Team. Read more here: https://lnkd.in/esKS3xRz Congratulations Katherine! 👏

Today, Prof Alan Boyd will be at Bionow's 2-day Oncology and Precision Medicine Conference at the Radnor Building in Alderley Park. The second day of the conference will focus on the impact precision medicine is having on patients in cancer detection, treatment and prevention as well as more widely. Professor Boyd will chair the "State of the Nation" panel discussion on this day. #Oncology #PrecisionMedicine #Networking #LifeSciences

We are delighted to welcome regulatory affairs professional, Matthew O'Connor, who joins Boyds as Senior Manager, Regulatory Affairs. Commenting on joining the Boyds team, Matt says “I am really excited about this opportunity with Boyds and particularly interested in working on ATMP products with such an expert team. I hope to bring all the experience I have gained over the last five years in regulatory affairs as well as scientific knowledge and understanding, having also worked in academic research, to bring further value to Boyds’ clients.” Read the full appointment story here: https://lnkd.in/ebXBHcEb

Congratulations to the 40 new Fellows and 13 new Honorary Fellows for 2024! Our Fellows and Honorary Fellows play an important role in the Society. Through their work, they further all disciplines of pharmacology in the discovery, development and use of medicines, and inspire and support members at earlier stages of their career or study. Read more: https://ow.ly/R5C950UmlUi

Boyds is thrilled to announce that Professor Alan Boyd has been awarded a prestigious Fellowship by the British Pharmacological Society, recognising his significant contributions to pharmacology. Fellows and Honorary Fellows play a vital role in advancing pharmacology through their work in the discovery, development, and application of medicines. Their leadership inspires and supports the next generation of professionals in the field. Read the full announcement here: https://lnkd.in/eqpfs6R6

Last night members of the Boyds regulatory team attended the TOPRA - The Organisation for Professionals in Regulatory Affairs awards for Regulatory Excellence held at the Chartered Accountants Hall in London.   We were thrilled to be named finalists in the Contribution category for Eamonn McGowran’s significant contribution to regulatory affairs, the Horizon category for Monica Pianella’s outstanding ability with fewer than five years’ experience in the profession and the Communication category for our Conversations in Drug Development podcast.   Huge congratulations to those who won awards last night. The team had a fantastic time at the event and enjoyed networking with industry peers throughout the evening, read more about the awards here: https://lnkd.in/es5pa_j2  #TOPRA #TOPRAAwards #TOPRA2024 #RegulatoryAffairs

Happy Thanksgiving to all our valued clients, colleagues, and friends in the United States 🍁🦃 #HappyThanksgiving

The FDA recently published a new FAQs guidance for developing cellular and gene therapy products, providing clarity on regulatory expectations, including defining investigational new drug (#IND) requirements, clinical trial design, and safety protocols. The guidance addresses common questions about preclinical data, manufacturing processes, and potency testing, emphasizing the importance of early FDA consultation and adherence to good manufacturing practices (GMP). For more details, access the full guidance document here: https://lnkd.in/es726_NG To discuss this guidance document further, please get in touch at info@boydconsultants.com and a member of the Boyds Regulatory team will be happy to help.

Want to join an award-winning regulatory team and work on a range of exciting, cutting-edge medicines? 📣 We are hiring! - Senior Manager / Associate Director (Dependent on experience), Regulatory Affairs, US-based (remote working) - Senior Director, Regulatory Affairs, UK-based To find out more along with details on how to apply, visit https://lnkd.in/eGwAt2hg #cellandgenetherapy #vacancies #regulatoryaffairs #regulatoryjobs #drugdevelopment

On Monday, Vice President of Business Development, Neil Fish, is heading to London Life Sciences Week (LLSW), first stop Investival Showcase hosted by LSX - partnering for Life Science eXecutives. 📍 Tobacco Dock, London, UK 📅 18 November, 2024 If you are around for London Life Sciences Week and would like to find out more about Boyds' capabilities in accelerating drug development programs, get in touch at info@boydconsultants.com to schedule a chat with Neil. #LondonLifeSciencesWeek #LLSW2024 #BiotechCommunity #LifeSciences #LondonLifeSciences BioIndustry Association (BIA) MedCity #Investival24